Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
This is a Prospective, Open-label, Single-Arm, Multi-center phase II clinical trial
evaluating the efficacy and safety of Apatinib for Chemotherapy Failure Ⅳ Stage Soft Tissue
Sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Collaborators:
Fudan University Gansu Cancer Hospital Liaoning Tumor Hospital & Institute Zhejiang Cancer Hospital